Intra-articular laser treatment plus Platelet Rich Plasma (PRP) significantly reduces pain in many patients who had failed prior PRP treatment
| Autor: | Alexander Dawes, Angelo Dizon, Susan Finkle, Chadwick C. Prodromos |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
low level laser
musculoskeletal diseases medicine.medical_specialty Joint replacement medicine.medical_treatment lcsh:Medicine Arthritis Osteoarthritis Article 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine Intra articular Pain control medicine In patient Adverse effect platelet rich plasma Low level laser therapy General Environmental Science 030203 arthritis & rheumatology business.industry Laser treatment lcsh:R General Engineering osteoarthrosis 030206 dentistry medicine.disease Surgery Platelet-rich plasma intra-articular laser General Earth and Planetary Sciences business After treatment |
| Zdroj: | Medicines, Vol 6, Iss 3, p 75 (2019) Medicines Volume 6 Issue 3 |
| DOI: | 10.1117/12.2287940 |
| Popis: | Background: In our practice, Platelet Rich Plasma (PRP) injections effectively reduce pain in most, but not all, arthritic patients. When PRP treatment fails, joint replacement surgery is often the only good alternative. Surface Low-Level-Laser-Therapy (LLLT) has not been helpful for osteoarthrosis in our experience. We hypothesized that intra-articular laser (IAL) treatment combined with PRP would improve results in patients with prior ineffective PRP treatment. Methods: We offered Intra-articular Low-Level-Laser-Therapy (IAL) treatment simultaneously with repeat PRP injection to patients who had received no benefit from PRP alone. They were the treatment and also historical control group since all had failed PRP treatment alone. Thirty joints were treated: 22 knees, 4 hips, 2 shoulder glenohumeral joints and 2 first carpo-metacarpal (1st CMC). Results: No adverse events were seen at any time after treatment in any patient. Twenty-eight joints were available for re-evaluation: &ge 40% improvement was seen in 46% (6 months), 32% (12 months) and 32% (24 months) post-treatment. Mean SANE scores improved significantly at 1 and 2 years. Thirteen patients failed treatment and had joint replacement. Conclusions: PRP with IAL allowed avoidance of surgery and good pain control at least two years post-treatment in nearly half of patients who had failed PRP treatment alone. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|